Shaoxing Jingxin Pharmaceutical Co., Ltd.

Shangyu Jingxin Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Zhejiang Jingxin Pharmaceutical Joint-stock Co., Ltd., which is one of China's top 100 pharmaceutical enterprises and a listed pharmaceutical company. The company mainly produces APIs (levofloxacin series, gatifloxacin series, ciprofloxacin series, loratadine, simvastatin, sertraline hydrochloride, ofloxacin, etc.) and is one of the largest production bases of quinolone APIs in China. The company has fully passed the national GMP certification and ISO14001 certification; simvastatin has obtained the COS certificate; ciprofloxacin hydrochloride has obtained the COS certificate, French GMP certificate, EU GMP certificate, and KFDA registration certificate. The company has repeatedly won honorary titles at the provincial and municipal levels; the "Jingxin" trademark is a Zhejiang Provincial Famous Trademark and a China Well-known Trademark; "Jingxin Pharmaceutical" has been rated as a Zhejiang Provincial Famous Trade Name; products such as "simvastatin" are Zhejiang Famous Brand Products; multiple products such as "levofloxacin carboxylic acid", "loratadine and preparations", and "gatifloxacin mesylate and preparations" have been listed as National Torch Plan projects, and the "sertraline hydrochloride" project has been included in the National Biomedical High-tech Industrialization Demonstration Project.